Skip to main content
AmigoFish

Episode 537 - Uromigos Live 2026 – Sequencing of Therapy Across the Continuum of Advanced Prostate Cancer

From The Uromigos · · 49 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Several third agents added to the ADT/ARPI backbone in mHSPC have emerged in the last year including radioligands and PARP inhibitors. Navigating application to individual patients is discussed by our expert panel.

Back to The Uromigos · Report a problem